NIKEM RESEARCH SRL has a total of 45 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Italy. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are XOC PHARMACEUTICALS INC, STOICESCU DAN and SANOFI AVENTIS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Italy | 4 | |
#4 | United States | 3 | |
#5 | Argentina | 2 | |
#6 | China | 2 | |
#7 | Hungary | 2 | |
#8 | Brazil | 1 | |
#9 | Canada | 1 | |
#10 | Colombia | 1 | |
#11 | Czechia | 1 | |
#12 | EAPO (Eurasian Patent Organization) | 1 | |
#13 | Gulf Cooperation Council | 1 | |
#14 | Hong Kong | 1 | |
#15 | Croatia | 1 | |
#16 | Israel | 1 | |
#17 | Malaysia | 1 | |
#18 | New Zealand | 1 | |
#19 | Serbia | 1 | |
#20 | Saudi Arabia | 1 | |
#21 | Taiwan | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Farina Carlo | 28 |
#2 | Gagliardi Stefania | 27 |
#3 | Parini Carlo | 9 |
#4 | Ghelardini Carla | 8 |
#5 | Martinelli Marisa | 8 |
#6 | Misiano Paola | 8 |
#7 | Laudanna Carlo | 4 |
#8 | Novella Pietro A T | 4 |
#9 | Constantin Gabriela | 4 |
#10 | Nadler Guy Marguerite Marie Ge | 3 |
Publication | Filing date | Title |
---|---|---|
EP1925304A1 | Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents | |
EP1873150A1 | Fluorinated indoleamides useful as ligands of the ORL-1 receptor | |
EP1779848A1 | V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases | |
EP1779849A1 | V-ATPase inhibitors for the treatment of septic shock | |
WO2005105078A1 | Indole derivatives useful for treating resistance to antitumour agents | |
EP1676843A1 | Substituted indole ligands for the ORL-1 receptor | |
WO2005000845A2 | Bicyclic derivatives as nk-1 and nk-2 antagonists | |
CA2520008A1 | Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof |